title: Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies.
abstract: Within the framework of hepatitis C virus (HCV) prevalence monitoring, we evaluated oral fluid (OF), which is richer in IgG than whole saliva, as a possible alternative to serum for the detection of HCV antibodies. Paired OF and serum samples were collected from 90 individuals, including 45 HCV-positives and 45 HCV-negatives. The detection of HCV antibodies in both serum and OF was performed using the Ortho HCV 3.0 SAVe enzyme-linked immunosorbent assay (ELISA) (Ortho-Clinical Diagnostics, Inc., Raritan, NJ), but a modified, more sensitive protocol was used to process OF. The sensitivity and specificity of this assay were 86.67% (95% confidence interval (CI): 72.51-94.46%) and 100% (95% CI: 90.20-99.80%) in OF and 100% in serum. The correlation obtained between both types of clinical specimens was excellent (k: 0.87, 95% CI: 0.66-1.07). However, the negative predictive value (NPV) of the assay in OF decreased with the prevalence of HCV infection in the population studied. Our results suggest that the modified Ortho HCV 3.0 SAVe ELISA is suitable for the detection of HCV antibodies in OF for epidemiological studies. Using this assay, we observed an unadjusted anti-HCV prevalence of 78.6% among a population of intravenous drug users; when adjusted to account for assay sensitivity, this prevalence may be closer to 90%.
authors.affiliation: Microbiology Service, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
authors.forename: V
authors.initials: V
authors.lastname: González
authors.forename: E
authors.initials: E
authors.lastname: Martró
authors.forename: C
authors.initials: C
authors.lastname: Folch
authors.forename: A
authors.initials: A
authors.lastname: Esteve
authors.forename: L
authors.initials: L
authors.lastname: Matas
authors.forename: A
authors.initials: A
authors.lastname: Montoliu
authors.forename: J R
authors.initials: JR
authors.lastname: Grífols
authors.forename: F
authors.initials: F
authors.lastname: Bolao
authors.forename: C
authors.initials: C
authors.lastname: Tural
authors.forename: R
authors.initials: R
authors.lastname: Muga
authors.forename: J V
authors.initials: JV
authors.lastname: Parry
authors.forename: V
authors.initials: V
authors.lastname: Ausina
authors.forename: J
authors.initials: J
authors.lastname: Casabona
mesh_terms: D000328:Adult; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D016174:Hepacivirus / Q000276:immunology*; D006526:Hepatitis C / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology*; D018937:Hepatitis C Antibodies / Q000032:analysis* / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D015995:Prevalence; D012463:Saliva / Q000276:immunology*; D012680:Sensitivity and Specificity; D015819:Substance Abuse, Intravenous; D014773:Virology / Q000379:methods*
chemical_list: D018937:Hepatitis C Antibodies